Antibodies Responses to SARS-CoV-2 in a Large Cohort of Vaccinated Subjects and Seropositive Patients

COVID-19 is a current global threat, and the characterization of antibody response is vitally important to update vaccine development and strategies. In this study we assessed SARS-CoV-2 antibody concentrations in SARS-CoV-2 positive patients (N = 272) and subjects vaccinated with the BNT162b2 m-RNA...

Descripción completa

Detalles Bibliográficos
Autores principales: Amodio, Emanuele, Capra, Giuseppina, Casuccio, Alessandra, Grazia, Simona De, Genovese, Dario, Pizzo, Stefano, Calamusa, Giuseppe, Ferraro, Donatella, Giammanco, Giovanni Maurizio, Vitale, Francesco, Bonura, Floriana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309986/
https://www.ncbi.nlm.nih.gov/pubmed/34358130
http://dx.doi.org/10.3390/vaccines9070714

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309986/
https://www.ncbi.nlm.nih.gov/pubmed/34358130
http://dx.doi.org/10.3390/vaccines9070714

Ejemplares similares